GSK3511294 (Depemokimab)

depemokimab · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK3511294 (Depemokimab), covering 2024-11-29 to 2024-11-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype [Phase 3]